OA12.05 APOLO: Phase II Trial of Induction Chemo-Immunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC
Provencio, M., Campos, B., Guirado, M., Vilà, L., Campelo, M.R. García, Dorta, M., Vázquez Estévez, S., Ferrández, A., Sala, M.A., Ortega, A.L., Blasco, A., Insa, A., Areses, M.C., Sullivan, I., López Castro, R., Calvo, V., Rodríguez - Abreu, D., Bosch-Barrera, J., López-Martín, A., Marsé, R., Torrado, L., Matskov, K., Giner, J., Fernández Bruno, M., Sánchez Saugar, E., Martínez-Toledo, C., Cruz-Bermudez, A.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
P3.08E.04 TCR Metrics as Predictive Biomarkers of Response and Survival after Perioperative Chemoimmunotherapy. NADIM & NADIM II Trials
Martínez-Toledo, C., Sierra, B., Molina-Alejandre, M., Casarrubios, M., Calvo, V., Nadal, E., García Campelo, M.R., Martínez-Martí, A., Garrido, A., Massutí, B., Insa, A., De Castro, J., Dómine, M., González-Larriba, J.L., Majem, M., Ponce, S., Barneto, I., Aguilar, A., Martín-López, J., Provencio, M., Cruz- Bermúdez, A.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
187P Tissue B-cell receptor repertoire as biomarker of complete pathological response in NSCLC patients treated with neoadjuvant chemoimmunotherapy (NADIM trials)
Sierra-Rodero, B., Martínez-Toledo, C., Molina-Alejandre, M., Calvo, V., Nadal, E., Sureda, B. Massuti, Campelo, R. García, Ojea, C. Gonzalez, Martinez-Marti, A., Gomez, M. Domine, Aix, S. Ponce, Molla, M.A. Insa, De Castro Carpeno, J., Majem, M., Aranda, I.C. Barneto, Rodriguez-Abreu, D., del Barco, E., Dols, M. Cobo, Pulla, M. Provencio, Cruz-Bermudez, A.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article